Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-10-04
DOI
10.3389/fphar.2017.00693
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity
- (2016) H. Herschel Conaway et al. BONE
- Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway
- (2016) Giuseppe Esposito et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Meclizine-induced enhanced glycolysis is neuroprotective in Parkinson disease cell models
- (2016) Chien Tai Hong et al. Scientific Reports
- Meclozine Promotes Longitudinal Skeletal Growth in Transgenic Mice with Achondroplasia Carrying a Gain-of-Function Mutation in theFGFR3Gene
- (2015) Masaki Matsushita et al. ENDOCRINOLOGY
- Epoxyeicosanoids suppress osteoclastogenesis and prevent ovariectomy-induced bone loss
- (2015) Hanfeng Guan et al. FASEB JOURNAL
- Amlexanox Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss
- (2015) Yong Zhang et al. Scientific Reports
- Meclizine Preconditioning Protects the Kidney Against Ischemia–Reperfusion Injury
- (2015) Seiji Kishi et al. EBioMedicine
- Vitamin K: Novel molecular mechanisms of action and its roles in osteoporosis
- (2013) Kotaro Azuma et al. Geriatrics & Gerontology International
- Meclozine Facilitates Proliferation and Differentiation of Chondrocytes by Attenuating Abnormally Activated FGFR3 Signaling in Achondroplasia
- (2013) Masaki Matsushita et al. PLoS One
- Osteoclast migration, differentiation and function: novel therapeutic targets for rheumatic diseases
- (2012) J. Kikuta et al. RHEUMATOLOGY
- Inhibition of NF-κB by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells
- (2011) Andrea Mencarelli et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Meclizine Metabolism and Pharmacokinetics: Formulation on Its Absorption
- (2011) Zhijun Wang et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Evidence for osteocyte regulation of bone homeostasis through RANKL expression
- (2011) Tomoki Nakashima et al. NATURE MEDICINE
- Meclizine is neuroprotective in models of Huntington's disease
- (2010) V. M. Gohil et al. HUMAN MOLECULAR GENETICS
- Pregnane X receptor knockout mice display osteopenia with reduced bone formation and enhanced bone resorption
- (2010) Kotaro Azuma et al. JOURNAL OF ENDOCRINOLOGY
- Differential Effect of Meclizine on the Activity of Human Pregnane X Receptor and Constitutive Androstane Receptor
- (2010) A. J. Lau et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis
- (2010) Vishal M Gohil et al. NATURE BIOTECHNOLOGY
- Metabolomics reveals a novel vitamin E metabolite and attenuated vitamin E metabolism upon PXR activation
- (2009) Joo-Youn Cho et al. JOURNAL OF LIPID RESEARCH
- The Osteoclast: Friend or Foe?
- (2008) Deborah V. Novack et al. Annual Review of Pathology-Mechanisms of Disease
- The pregnane X receptor: from bench to bedside
- (2008) Xiaochao Ma et al. Expert Opinion on Drug Metabolism & Toxicology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search